Recent Progress in Rare Oncogenic Drivers and Targeted Therapy For Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is frequently associated with oncogenic driver mutations, which play an important role in carcinogenesis and cancer progression. Targeting epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase rearrangements has become standard therapy fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yijia, Cao, Rui, Zhang, Xiangyan, Huang, Letian, Sun, Li, Zhao, Jianzhu, Ma, Jietao, Han, Chengbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886531/
https://www.ncbi.nlm.nih.gov/pubmed/31819518
http://dx.doi.org/10.2147/OTT.S230309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886531/
https://www.ncbi.nlm.nih.gov/pubmed/31819518
http://dx.doi.org/10.2147/OTT.S230309

Ejemplares similares